MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about compliance certificate

04 Jul 2024 Evaluate
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Glaxosmithkline Pharmaceuticals has informed that it enclosed a copy of the Certificate received from Kfin Technologies, the Registrar and share Transfer Agent of the Company, for the quarter ended 30th June 2024.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1854.15
Dr. Reddys Labs. 1147.70
Cipla 1360.10
Lupin 2046.00
Zydus Lifesciences 1110.00
View more..